methylphosphonothiolate has been researched along with oligonucleotides in 1 studies
| Studies (methylphosphonothiolate) | Trials (methylphosphonothiolate) | Recent Studies (post-2010) (methylphosphonothiolate) | Studies (oligonucleotides) | Trials (oligonucleotides) | Recent Studies (post-2010) (oligonucleotides) |
|---|---|---|---|---|---|
| 9 | 0 | 1 | 23,128 | 245 | 7,331 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aartsma-Rus, A; Bosgra, S; Tanganyika-de Winter, C; van Putten, M | 1 |
1 other study(ies) available for methylphosphonothiolate and oligonucleotides
| Article | Year |
|---|---|
Nonclinical Exon Skipping Studies with 2'-O-Methyl Phosphorothioate Antisense Oligonucleotides in mdx and mdx-utrn-/- Mice Inspired by Clinical Trial Results.
Topics: Animals; Clinical Trials as Topic; Dystrophin; Exons; Genetic Therapy; Humans; Mice; Mice, Inbred mdx; Morpholinos; Muscular Atrophy, Spinal; Muscular Dystrophy, Duchenne; Oligonucleotides; Oligonucleotides, Antisense; Organothiophosphorus Compounds; Utrophin | 2019 |